Over the next two years, researchers will track A1C, time-in-range, insulin use, and weight changes to see if results warrant FDA approval a key step toward insurance coverage
DPP-4 inhibitors which increase levels of GLP-1, a hormone that helps reduce blood sugar levels have been approved for treatment of type 2 diabetes since 2006
We demonstrate that gliT confers resistance to exogenous gliotoxin, independently of the extent of gliT expression, following transformation in nave hosts, A
There is no vial to draw from, no syringe to read, no concentration to verify
Month 1: 0.5 mg, once daily Month 2: 1 mg, once daily Month 3: 1.5 mg, once daily Month 4: 2 mg, once daily Month 5 and beyond (maintenance): 2.5 mg, once daily Medication is prescribed only after consultation with a licensed provider to determine appropriateness